药物信息为Jolessa™ (levonorgestrel/ethinyl estradiol tablets) 0.15 mg / 0.03 mg (Barr Laboratories, Inc.): DESCRIPTION
- DESCRIPTION
- INDICATIONS AND USAGE
- CONTRAINDICATIONS
- INFORMATION FOR THE PATIENT
- ADVERSE REACTIONS
- OVERDOSAGE
- NONCONTRACEPTIVE HEALTH BENEFITS
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- BRIEF SUMMARY PATIENT PACKAGE INSERT
- DETAILED PATIENT LABELING
- PRINCIPAL DISPLAY PANEL
- 外部链接相关的Jolessa™ (levonorgestrel/ethinyl estradiol tablets) 0.15 mg / 0.03 mg (Barr Laboratories, Inc.)
Jolessa™ (levonorgestrel/ethinyl estradiol tablets) is an extended-cycle oral contraceptive consisting of 84 pink active tablets each containing 0.15 mg of levonorgestrel, a synthetic progestogen and 0.03 mg of ethinyl estradiol, and 7 white inert tablets (without hormones).
The chemical formula of levonorgestrel USP is 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17a)-, (-)-, and the chemical formula of ethinyl estradiol USP is 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17a)-. The structural formulas are as follows:


Each pink active tablet contains the following inactive ingredients: anhydrous lactose NF, FD&C blue no. 1, FD&C red no. 40, hydroxypropyl methylcellulose USP, microcrystalline cellulose NF, polyethylene glycol NF, magnesium stearate NF, polysorbate 80 NF, and titanium dioxide USP. Each white inert tablet contains the following inactive ingredients: anhydrous lactose NF, hydroxypropyl methylcellulose USP, microcrystalline cellulose NF, and magnesium stearate NF.
- Drug Information Provided by National Library of Medicine (NLM).
